BUSINESS DEVELOPMENT
2010–2014
This overview may include historically adjusted values in order to ensure comparability with 2014.
Merck Group → Key Figures
Show table| € million | 2010 | 2011 | 2012 | 2013 | 2014 | Change in % | |
|---|---|---|---|---|---|---|---|
| Earnings performance | |||||||
| Total revenues | 9,291 | 10,276 | 11,173 | 11,095 | 11,501 | 3.7 | |
| Sales | 8,929 | 9,906 | 10,741 | 10,700 | 11,291 | 5.5 | |
| Operating result (EBIT) | 1,113 | 1,132 | 964 | 1,611 | 1,762 | 9.4 | |
| Margin (% of sales) | 12.5 | 11.4 | 9.0 | 15.1 | 15.6 | ||
| EBITDA | 2,457 | 2,731 | 2,360 | 3,069 | 3,123 | 1.7 | |
| Margin (% of sales) | 27.5 | 27.6 | 22.0 | 28.7 | 27.7 | ||
| One-time items | –88 | 7 | -605 | –184 | -265 | 43.9 | |
| EBITDA pre one-time items | 2,545 | 2,724 | 2,965 | 3,253 | 3,388 | 4.1 | |
| Margin (% of sales) | 28.5 | 27.5 | 27.6 | 30.4 | 30.0 | ||
| Profit before income tax | 861 | 839 | 709 | 1,389 | 1,557 | 12.1 | |
| Profit after tax | 642 | 618 | 579 | 1,209 | 1,165 | -3.7 | |
| Earnings per share (in €)1 | 1.45 | 1.39 | 1.30 | 2.77 | 2.66 | -4.0 | |
| Assets and liabilities | |||||||
| Total assets | 22,388 | 22,122 | 21,643 | 20,819 | 26,010 | 24.9 | |
| Non-current assets | 16,724 | 15,723 | 15,017 | 13,434 | 15,530 | 15.6 | |
| – thereof intangible assets (incl, goodwill) | 12,484 | 11,764 | 10,945 | 9,867 | 11,396 | 15.5 | |
| – thereof property, plant and equipment | 3,241 | 3,113 | 2,954 | 2,647 | 2,990 | 13.0 | |
| Current assets | 5,664 | 6,399 | 6,626 | 7,385 | 10,480 | 41.9 | |
| – thereof cash and cash equivalents | 944 | 938 | 730 | 981 | 2,879 | 193.5 | |
| – thereof trade accounts receivable | 2,296 | 2,328 | 2,115 | 2,021 | 2,236 | 10.6 | |
| – thereof inventories | 1,674 | 1,691 | 1,534 | 1,474 | 1,660 | 12.6 | |
| Financial liabilities | 5,484 | 5,539 | 4,454 | 3,698 | 5,637 | 52.4 | |
| – thereof current | 356 | 1,394 | 1,091 | 440 | 2,076 | - | |
| – thereof non-current | 5,127 | 4,145 | 3,362 | 3,257 | 3,561 | 9.3 | |
| Net equity | 10,372 | 10,494 | 10,415 | 11,069 | 11,801 | 6.6 | |
| Liquidity | |||||||
| Capital expenditure on intangible assets2 | 104 | 80 | 144 | 110 | 143 | 30.8 | |
| Capital expenditure on property, plant and equipment2 | 396 | 366 | 329 | 407 | 481 | 18.1 | |
| Business free cash flow | 1,275 | 2,262 | 2,969 | 2,960 | 2,605 | –12.0 | |
| Net financial debt | 4,484 | 3,484 | 1,926 | 307 | 559 | 82.3 | |
| Other key data | |||||||
| Equity ratio (in %) | 46.3 | 47.4 | 48.1 | 53.2 | 45.4 | ||
| Research and development3 | 1,397 | 1,514 | 1,511 | 1,507 | 1,704 | 13.1 | |
| Dividend per share (in €) | 1.25 | 1.50 | 1.70 | 1.90 | 1.00 4 | - | |
| Employees (number as of December 31) | 40,562 | 40,676 | 38,847 | 38,154 | 39,639 | 3.9 | |
|
|||||||